Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 175 articles:
HTML format
Text format



Single Articles


    January 2017
  1. RUSCITTI P, Cipriani P, Masedu F, Romano S, et al
    Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study.
    PLoS One. 2017;12:e0170108.
    PubMed     Text format     Abstract available


  2. CONIGLIARO P, Ciccacci C, Politi C, Triggianese P, et al
    Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis.
    PLoS One. 2017;12:e0169956.
    PubMed     Text format     Abstract available


  3. MAKOVEICHUK E, Ruge T, Nilsson S, Sodergren A, et al
    High Concentrations of Angiopoietin-Like Protein 4 Detected in Serum from Patients with Rheumatoid Arthritis Can Be Explained by Non-Specific Antibody Reactivity.
    PLoS One. 2017;12:e0168922.
    PubMed     Text format     Abstract available


  4. JORGENSEN TS, Turesson C, Kapetanovic M, Englund M, et al
    EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.
    PLoS One. 2017;12:e0169946.
    PubMed     Text format     Abstract available


  5. FISHER A, Bassett K, Goel G, Stanely D, et al
    Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis-A Meta-Analysis.
    PLoS One. 2017;12:e0172646.
    PubMed     Text format     Abstract available


  6. BALANDRAUD N, Texier G, Massy E, Muis-Pistor O, et al
    Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective study.
    PLoS One. 2017;12:e0171623.
    PubMed     Text format     Abstract available


  7. DEYAB G, Hokstad I, Whist JE, Smastuen MC, et al
    Anti-rheumatic treatment is not associated with reduction of pentraxin 3 in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
    PLoS One. 2017;12:e0169830.
    PubMed     Text format     Abstract available


  8. YANG B, Huang Z, Feng W, Wei W, et al
    Correction: The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis.
    PLoS One. 2017;12:e0173531.
    PubMed     Text format     Abstract available


  9. XU N, Zhao S, Xue H, Fu W, et al
    Associations of perceived social support and positive psychological resources with fatigue symptom in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0173293.
    PubMed     Text format     Abstract available


  10. CROWSON CS, Rollefstad S, Kitas GD, van Riel PL, et al
    Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0174656.
    PubMed     Text format     Abstract available


  11. HALLAJZADEH J, Safiri S, Mansournia MA, Khoramdad M, et al
    Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis.
    PLoS One. 2017;12:e0170361.
    PubMed     Text format     Abstract available


  12. PARADOWSKA-GORYCKA A, Sowinska A, Pawlik A, Malinowski D, et al
    FLT-1 gene polymorphisms and protein expression profile in rheumatoid arthritis.
    PLoS One. 2017;12:e0172018.
    PubMed     Text format     Abstract available


  13. CROWSON CS, Rollefstad S, Kitas GD, van Riel PL, et al
    Correction: Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0175605.
    PubMed     Text format     Abstract available


  14. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Text format     Abstract available


  15. MOOTS RJ, Xavier RM, Mok CC, Rahman MU, et al
    The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study.
    PLoS One. 2017;12:e0175207.
    PubMed     Text format     Abstract available


  16. BOO S, Oh H, Froelicher ES, Suh CH, et al
    Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0176291.
    PubMed     Text format     Abstract available


  17. IWAMOTO N, Tsuji S, Takatani A, Shimizu T, et al
    Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0177057.
    PubMed     Text format     Abstract available


  18. KOGA T, Okada A, Fukuda T, Hidaka T, et al
    Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan.
    PLoS One. 2017;12:e0175281.
    PubMed     Text format     Abstract available


  19. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Correction: Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0178309.
    PubMed     Text format     Abstract available


  20. LIM CH, Chen HH, Chen YH, Chen DY, et al
    The risk of tuberculosis disease in rheumatoid arthritis patients on biologics and targeted therapy: A 15-year real world experience in Taiwan.
    PLoS One. 2017;12:e0178035.
    PubMed     Text format     Abstract available


  21. MORI S, Yoshitama T, Hidaka T, Sakai F, et al
    Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
    PLoS One. 2017;12:e0179179.
    PubMed     Text format     Abstract available


  22. MATEEN S, Moin S, Shahzad S, Khan AQ, et al
    Level of inflammatory cytokines in rheumatoid arthritis patients: Correlation with 25-hydroxy vitamin D and reactive oxygen species.
    PLoS One. 2017;12:e0178879.
    PubMed     Text format     Abstract available


  23. MOOTS RJ, Xavier RM, Mok CC, Rahman MU, et al
    Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventi
    PLoS One. 2017;12:e0179308.
    PubMed     Text format     Abstract available


  24. BUONDONNO I, Rovera G, Sassi F, Rigoni MM, et al
    Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study.
    PLoS One. 2017;12:e0178463.
    PubMed     Text format     Abstract available


  25. HUNG YM, Lin L, Chen CM, Chiou JY, et al
    The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.
    PLoS One. 2017;12:e0179081.
    PubMed     Text format     Abstract available


  26. ZOU K, Xiao FK, Li HY, Zhou Q, et al
    Risk of cardiovascular disease in Chinese patients with rheumatoid arthritis: A cross-sectional study based on hospital medical records in 10 years.
    PLoS One. 2017;12:e0180376.
    PubMed     Text format     Abstract available


  27. VIDAL-BRALO L, Perez-Pampin E, Regueiro C, Montes A, et al
    Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients.
    PLoS One. 2017;12:e0180144.
    PubMed     Text format     Abstract available


  28. MURPHY D, Mattey D, Hutchinson D
    Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
    PLoS One. 2017;12:e0180655.
    PubMed     Text format     Abstract available


  29. LOUPASAKIS K, Kuo D, Sokhi UK, Sohn C, et al
    Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes.
    PLoS One. 2017;12:e0179762.
    PubMed     Text format     Abstract available


  30. RUSCITTI P, Ursini F, Cipriani P, Liakouli V, et al
    Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study.
    PLoS One. 2017;12:e0181203.
    PubMed     Text format     Abstract available


  31. WANG W, Liu J, Yang B, Ma Z, et al
    Modulation of platelet-derived microparticles to adhesion and motility of human rheumatoid arthritis fibroblast-like synoviocytes.
    PLoS One. 2017;12:e0181003.
    PubMed     Text format     Abstract available


  32. HUANG CM, Chen HH, Chen DC, Huang YC, et al
    Rheumatoid arthritis is associated with rs17337023 polymorphism and increased serum level of the EGFR protein.
    PLoS One. 2017;12:e0180604.
    PubMed     Text format     Abstract available


  33. GILLOOLY KM, Pulicicchio C, Pattoli MA, Cheng L, et al
    Bruton's tyrosine kinase inhibitor BMS-986142 in experimental models of rheumatoid arthritis enhances efficacy of agents representing clinical standard-of-care.
    PLoS One. 2017;12:e0181782.
    PubMed     Text format     Abstract available


  34. LUUKKONEN J, Pascual LM, Patlaka C, Lang P, et al
    Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.
    PLoS One. 2017;12:e0182904.
    PubMed     Text format     Abstract available


  35. VAANANEN T, Vuolteenaho K, Kautiainen H, Nieminen R, et al
    Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial.
    PLoS One. 2017;12:e0183294.
    PubMed     Text format     Abstract available


  36. TUNG CH, Lu MC, Lai NS, Wu SF, et al
    Tumor necrosis factor-alpha blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.
    PLoS One. 2017;12:e0183726.
    PubMed     Text format     Abstract available


  37. HURNAKOVA J, Hulejova H, Zavada J, Hanova P, et al
    Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study.
    PLoS One. 2017;12:e0183420.
    PubMed     Text format     Abstract available


  38. CHEN JQ, Papp G, Poliska S, Szabo K, et al
    MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjogren's syndrome.
    PLoS One. 2017;12:e0174585.
    PubMed     Text format     Abstract available


  39. JEONG S, Yang H, Hwang H
    Evaluation of an automated connective tissue disease screening assay in Korean patients with systemic rheumatic diseases.
    PLoS One. 2017;12:e0173597.
    PubMed     Text format     Abstract available


  40. STONE DU, Fife D, Brown M, Earley KE, et al
    Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjogren's Syndrome.
    PLoS One. 2017;12:e0170249.
    PubMed     Text format     Abstract available


  41. PASMA A, Schenk C, Timman R, van 't Spijker A, et al
    Does non-adherence to DMARDs influence hospital-related healthcare costs for early arthritis in the first year of treatment?
    PLoS One. 2017;12:e0171070.
    PubMed     Text format     Abstract available


  42. WOO HJ, Yu C, Reifman J
    Collective Genetic Interaction Effects and the Role of Antigen-Presenting Cells in Autoimmune Diseases.
    PLoS One. 2017;12:e0169918.
    PubMed     Text format     Abstract available


  43. WALSH AM, Wechalekar MD, Guo Y, Yin X, et al
    Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways.
    PLoS One. 2017;12:e0183928.
    PubMed     Text format     Abstract available


  44. ZHOU R, Lin X, Li DY, Wang XF, et al
    Identification of novel genetic loci for osteoporosis and/or rheumatoid arthritis using cFDR approach.
    PLoS One. 2017;12:e0183842.
    PubMed     Text format     Abstract available


  45. EBINA K, Hirao M, Takagi K, Ueno S, et al
    Comparison of the effects of forefoot joint-preserving arthroplasty and resection-replacement arthroplasty on walking plantar pressure distribution and patient-based outcomes in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0183805.
    PubMed     Text format     Abstract available


  46. LIU R, Gao C, Chen H, Li Y, et al
    Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease.
    PLoS One. 2017;12:e0173301.
    PubMed     Text format     Abstract available


  47. SHIELDS KJ, Mollnes TE, Eidet JR, Mikkelsen K, et al
    Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases.
    PLoS One. 2017;12:e0174577.
    PubMed     Text format     Abstract available


  48. LACKNER A, Ficjan A, Stradner MH, Hermann J, et al
    It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjogren's Syndrome - A qualitative study.
    PLoS One. 2017;12:e0172056.
    PubMed     Text format     Abstract available


  49. MORIYA N, Shibasaki S, Karasaki M, Iwasaki T, et al
    The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells.
    PLoS One. 2017;12:e0169702.
    PubMed     Text format     Abstract available


  50. MOURA RA, Quaresma C, Vieira AR, Goncalves MJ, et al
    B-cell phenotype and IgD-CD27- memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis.
    PLoS One. 2017;12:e0182927.
    PubMed     Text format     Abstract available


  51. SCRIVO R, Massaro L, Barbati C, Vomero M, et al
    The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus.
    PLoS One. 2017;12:e0184449.
    PubMed     Text format     Abstract available


  52. PETERS M, Scharmga A, de Jong J, van Tubergen A, et al
    An automated algorithm for the detection of cortical interruptions on high resolution peripheral quantitative computed tomography images of finger joints.
    PLoS One. 2017;12:e0175829.
    PubMed     Text format     Abstract available


  53. WU MC, Xu X, Chen SM, Tyan YS, et al
    Impact of Sjogren's syndrome on Parkinson's disease: A nationwide case-control study.
    PLoS One. 2017;12:e0175836.
    PubMed     Text format     Abstract available


  54. QU S, Du Y, Chang S, Guo L, et al
    Common variants near IKZF1 are associated with primary Sjogren's syndrome in Han Chinese.
    PLoS One. 2017;12:e0177320.
    PubMed     Text format     Abstract available


  55. CHAO WC, Lin CH, Liao TL, Chen YM, et al
    Association between a history of mycobacterial infection and the risk of newly diagnosed Sjogren's syndrome: A nationwide, population-based case-control study.
    PLoS One. 2017;12:e0176549.
    PubMed     Text format     Abstract available


  56. BONAVENTURA P, Lamboux A, Albarede F, Miossec P, et al
    Regulatory effects of zinc on cadmium-induced cytotoxicity in chronic inflammation.
    PLoS One. 2017;12:e0180879.
    PubMed     Text format     Abstract available


  57. FIDELIX T, Czapkowski A, Azjen S, Andriolo A, et al
    Salivary gland ultrasonography as a predictor of clinical activity in Sjogren's syndrome.
    PLoS One. 2017;12:e0182287.
    PubMed     Text format     Abstract available


  58. RIFBJERG-MADSEN S, Christensen AW, Christensen R, Hetland ML, et al
    Pain and pain mechanisms in patients with inflammatory arthritis: A Danish nationwide cross-sectional DANBIO registry survey.
    PLoS One. 2017;12:e0180014.
    PubMed     Text format     Abstract available


  59. HUANG LG, Chen G, Chen DY, Chen HH, et al
    Factors associated with the risk of gingival disease in patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0186346.
    PubMed     Text format     Abstract available


  60. MAROUEN S, du Cailar G, Audo R, Lukas C, et al
    Sodium excretion is higher in patients with rheumatoid arthritis than in matched controls.
    PLoS One. 2017;12:e0186157.
    PubMed     Text format     Abstract available


  61. JARDEL S, Fabien N, Hot A, Vukusic S, et al
    Isolated positive anti-SS-B autoantibodies are not related to clinical features of systemic autoimmune diseases: Results from a routine population survey.
    PLoS One. 2017;12:e0185104.
    PubMed     Text format     Abstract available


  62. CHEN FY, Lee A, Ge S, Nathan S, et al
    Aire-deficient mice provide a model of corneal and lacrimal gland neuropathy in Sjogren's syndrome.
    PLoS One. 2017;12:e0184916.
    PubMed     Text format     Abstract available


  63. CHEN X, Utheim OA, Xiao J, Adil MY, et al
    Meibomian gland features in a Norwegian cohort of patients with primary Sjogren s syndrome.
    PLoS One. 2017;12:e0184284.
    PubMed     Text format     Abstract available


  64. LIN CH, Chen DY, Chao WC, Liao TL, et al
    Association between periodontitis and the risk of palindromic rheumatism: A nationwide, population-based, case-control study.
    PLoS One. 2017;12:e0182284.
    PubMed     Text format     Abstract available


  65. MENG Z, Klinngam W, Edman MC, Hamm-Alvarez SF, et al
    Interferon-gamma treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjogren's Syndrome.
    PLoS One. 2017;12:e0184781.
    PubMed     Text format     Abstract available


  66. KIM KH, Kim DH, Jeong HJ, Ryu JS, et al
    Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjgren's syndrome.
    PLoS One. 2017;12:e0183678.
    PubMed     Text format     Abstract available


  67. NARAYAN N, Mandhair H, Smyth E, Dakin SG, et al
    The macrophage marker translocator protein (TSPO) is down-regulated on pro-inflammatory 'M1' human macrophages.
    PLoS One. 2017;12:e0185767.
    PubMed     Text format     Abstract available


  68. STACK JR, Madigan A, Helbert L, Dunne E, et al
    Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.
    PLoS One. 2017;12:e0188027.
    PubMed     Text format     Abstract available


  69. YUAN M, Wang S, Yu L, Qu B, et al
    Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis.
    PLoS One. 2017;12:e0186795.
    PubMed     Text format     Abstract available


  70. STACK RJ, Southworth S, Fisher BA, Barone F, et al
    A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sjogren's Syndrome.
    PLoS One. 2017;12:e0187272.
    PubMed     Text format     Abstract available


    January 2016
  71. TOTOSON P, Maguin-Gate K, Nappey M, Wendling D, et al
    Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation.
    PLoS One. 2016;11:e0146744.
    PubMed     Text format     Abstract available


  72. WANG D, Li Y, Liu Y, He Y, et al
    Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity.
    PLoS One. 2016;11:e0146805.
    PubMed     Text format     Abstract available


  73. CREPALDI G, Scire CA, Carrara G, Sakellariou G, et al
    Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0146991.
    PubMed     Text format     Abstract available


  74. LIN J, Liu J, Davies ML, Chen W, et al
    Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis.
    PLoS One. 2016;11:e0146351.
    PubMed     Text format     Abstract available


  75. JANSSENS X, Decuman S, De Keyser F
    Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumatoid Arthritis.
    PLoS One. 2016;11:e0146688.
    PubMed     Text format     Abstract available


  76. WU Y, Chen W, Chen H, Zhang L, et al
    The Elevated Secreted Immunoglobulin D Enhanced the Activation of Peripheral Blood Mononuclear Cells in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0147788.
    PubMed     Text format     Abstract available


  77. TVETE IF, Natvig B, Gasemyr J, Meland N, et al
    Correction: Comparing Effects of Biologic Agents in Treating Patients with Rheumatoid Arthritis: A Multiple Treatment Comparison Regression Analysis.
    PLoS One. 2016;11:e0146633.
    PubMed     Text format     Abstract available


  78. AMARILYO G, Furst DE, Woo JM, Li W, et al
    Agreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research Project.
    PLoS One. 2016;11:e0147556.
    PubMed     Text format     Abstract available


  79. KRAGSTRUP TW, Jalilian B, Keller KK, Zhang X, et al
    Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response.
    PLoS One. 2016;11:e0148486.
    PubMed     Text format     Abstract available



  80. Correction: Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation.
    PLoS One. 2016;11:e0150874.
    PubMed     Text format     Abstract available


  81. KIM K, Bang SY, Yoo DH, Cho SK, et al
    Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus.
    PLoS One. 2016;11:e0150283.
    PubMed     Text format     Abstract available


  82. LIOU LB, Huang CC
    Sialyltransferase and Neuraminidase Levels/Ratios and Sialic Acid Levels in Peripheral Blood B Cells Correlate with Measures of Disease Activity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Pilot Study.
    PLoS One. 2016;11:e0151669.
    PubMed     Text format     Abstract available


  83. PUJADES-RODRIGUEZ M, Duyx B, Thomas SL, Stogiannis D, et al
    Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England.
    PLoS One. 2016;11:e0151245.
    PubMed     Text format     Abstract available


  84. IZUMI K, Kaneko Y, Hashizume M, Yoshimoto K, et al
    Correction: Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).
    PLoS One. 2016;11:e0152341.
    PubMed     Text format     Abstract available


  85. NAIR SC, Welsing PM, Choi IY, Roth J, et al
    A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis Patients.
    PLoS One. 2016;11:e0152362.
    PubMed     Text format     Abstract available


  86. MAIJER KI, Gudmann NS, Karsdal MA, Gerlag DM, et al
    Neo-Epitopes-Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified Arthritis.
    PLoS One. 2016;11:e0149329.
    PubMed     Text format     Abstract available


  87. WATANABE T, Takahashi N, Hirabara S, Ishiguro N, et al
    Hyaluronan Inhibits Tlr-4-Dependent RANKL Expression in Human Rheumatoid Arthritis Synovial Fibroblasts.
    PLoS One. 2016;11:e0153142.
    PubMed     Text format     Abstract available


  88. ORTEA I, Roschitzki B, Lopez-Rodriguez R, Tomero EG, et al
    Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study.
    PLoS One. 2016;11:e0153140.
    PubMed     Text format     Abstract available


  89. MATEEN S, Moin S, Khan AQ, Zafar A, et al
    Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0152925.
    PubMed     Text format     Abstract available


  90. LIAO TL, Lin CH, Chen YM, Chang CL, et al
    Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan.
    PLoS One. 2016;11:e0153217.
    PubMed     Text format     Abstract available


  91. COSTELLO R, Winthrop KL, Pye SR, Brown B, et al
    Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.
    PLoS One. 2016;11:e0153848.
    PubMed     Text format     Abstract available


  92. VERNEROVA L, Spoutil F, Vlcek M, Krskova K, et al
    A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study.
    PLoS One. 2016;11:e0153316.
    PubMed     Text format     Abstract available


  93. KOBAYASHI T, Ito S, Kobayashi D, Shimada A, et al
    Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0154182.
    PubMed     Text format     Abstract available


  94. ISMAIL E, Nofal OK, Sakthiswary R, Shaharir SS, et al
    The Clinical Significance of Interleukin-1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0153752.
    PubMed     Text format     Abstract available


  95. ZHOU SM, Fernandez-Gutierrez F, Kennedy J, Cooksey R, et al
    Defining Disease Phenotypes in Primary Care Electronic Health Records by a Machine Learning Approach: A Case Study in Identifying Rheumatoid Arthritis.
    PLoS One. 2016;11:e0154515.
    PubMed     Text format     Abstract available


  96. YANG B, Huang Z, Feng W, Wei W, et al
    The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis.
    PLoS One. 2016;11:e0155345.
    PubMed     Text format     Abstract available


  97. TUNCEL J, Haag S, Hoffmann MH, Yau AC, et al
    Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat.
    PLoS One. 2016;11:e0155936.
    PubMed     Text format     Abstract available


  98. ERIKSSON K, Nise L, Kats A, Luttropp E, et al
    Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study.
    PLoS One. 2016;11:e0155956.
    PubMed     Text format     Abstract available


  99. FRANSEN J, Kazemi-Bajestani SM, Bredie SJ, Popa CD, et al
    Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis.
    PLoS One. 2016;11:e0157360.
    PubMed     Text format     Abstract available


  100. QUATTROCCHI E, Ostergaard M, Taylor PC, van Vollenhoven RF, et al
    Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.
    PLoS One. 2016;11:e0157961.
    PubMed     Text format     Abstract available


  101. KANAAN SB, Onat OE, Balandraud N, Martin GV, et al
    Evaluation of X Chromosome Inactivation with Respect to HLA Genetic Susceptibility in Rheumatoid Arthritis and Systemic Sclerosis.
    PLoS One. 2016;11:e0158550.
    PubMed     Text format     Abstract available


  102. WAKURA D, Kotani T, Takeuchi T, Komori T, et al
    Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?
    PLoS One. 2016;11:e0158509.
    PubMed     Text format     Abstract available


  103. JIANG J, Li K, Wang F, Yang B, et al
    Effect of Marine-Derived n-3 Polyunsaturated Fatty Acids on Major Eicosanoids: A Systematic Review and Meta-Analysis from 18 Randomized Controlled Trials.
    PLoS One. 2016;11:e0147351.
    PubMed     Text format     Abstract available


  104. PUCHNER R, Edlinger M, Mur E, Eberl G, et al
    Interface Management between General Practitioners and Rheumatologists-Results of a Survey Defining a Concept for Future Joint Recommendations.
    PLoS One. 2016;11:e0146149.
    PubMed     Text format     Abstract available


  105. LISOWSKA B, Siewruk K, Lisowski A
    Substance P and Acute Pain in Patients Undergoing Orthopedic Surgery.
    PLoS One. 2016;11:e0146400.
    PubMed     Text format     Abstract available


  106. BONAVENTURA P, Lamboux A, Albarede F, Miossec P, et al
    A Feedback Loop between Inflammation and Zn Uptake.
    PLoS One. 2016;11:e0147146.
    PubMed     Text format     Abstract available


  107. LI L, Deng C, Chen S, Zhang S, et al
    Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis.
    PLoS One. 2016;11:e0159000.
    PubMed     Text format     Abstract available


  108. CHEN Y, Zheng J, Huang Q, Deng F, et al
    Autoantibodies against the Second Extracellular Loop of M3R Do neither Induce nor Indicate Primary Sjogren's Syndrome.
    PLoS One. 2016;11:e0149485.
    PubMed     Text format     Abstract available


  109. MARKOVICS A, Ocsko T, Katz RS, Buzas EI, et al
    Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
    PLoS One. 2016;11:e0160284.
    PubMed     Text format     Abstract available


  110. ATISHA-FREGOSO Y, Lima G, Pascual-Ramos V, Banos-Pelaez M, et al
    Rheumatoid Arthritis Disease Activity Is Determinant for ABCB1 and ABCG2 Drug-Efflux Transporters Function.
    PLoS One. 2016;11:e0159556.
    PubMed     Text format     Abstract available


  111. BREKELMANS MP, Fens N, Brinkman P, Bos LD, et al
    Smelling the Diagnosis: The Electronic Nose as Diagnostic Tool in Inflammatory Arthritis. A Case-Reference Study.
    PLoS One. 2016;11:e0151715.
    PubMed     Text format     Abstract available


  112. KAMI YN, Sumi M, Takagi Y, Sasaki M, et al
    Arterial Spin Labeling Imaging for the Parotid Glands of Patients with Sjogren's Syndrome.
    PLoS One. 2016;11:e0150680.
    PubMed     Text format     Abstract available


  113. GLANT TT, Ocsko T, Markovics A, Szekanecz Z, et al
    Characterization and Localization of Citrullinated Proteoglycan Aggrecan in Human Articular Cartilage.
    PLoS One. 2016;11:e0150784.
    PubMed     Text format     Abstract available


  114. SEOANE IV, Ortiz AM, Piris L, Lamana A, et al
    Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity.
    PLoS One. 2016;11:e0149141.
    PubMed     Text format     Abstract available


  115. RODRIGUEZ-CARRIO J, Alperi-Lopez M, Lopez P, Ballina-Garcia FJ, et al
    Non-Esterified Fatty Acids Profiling in Rheumatoid Arthritis: Associations with Clinical Features and Th1 Response.
    PLoS One. 2016;11:e0159573.
    PubMed     Text format     Abstract available


  116. NAVARRO-MILLAN I, Herrinton LJ, Chen L, Harrold L, et al
    Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability.
    PLoS One. 2016;11:e0149781.
    PubMed     Text format     Abstract available


  117. YI J, Zhu Y, Jia Y, Jiang H, et al
    The Annexin a2 Promotes Development in Arthritis through Neovascularization by Amplification Hedgehog Pathway.
    PLoS One. 2016;11:e0150363.
    PubMed     Text format     Abstract available


  118. PARADOWSKA-GORYCKA A, Pawlik A, Romanowska-Prochnicka K, Haladyj E, et al
    Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis.
    PLoS One. 2016;11:e0160769.
    PubMed     Text format     Abstract available


  119. SOUZA FB, Porfirio GJ, Andriolo BN, Albuquerque JV, et al
    Rituximab Effectiveness and Safety for Treating Primary Sjogren's Syndrome (pSS): Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0150749.
    PubMed     Text format     Abstract available


  120. NAIR SC, Jacobs JW, Bakker MF, Jahangier ZN, et al
    Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach.
    PLoS One. 2016;11:e0148791.
    PubMed     Text format     Abstract available


  121. MONTES A, Regueiro C, Perez-Pampin E, Boveda MD, et al
    Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies.
    PLoS One. 2016;11:e0161141.
    PubMed     Text format     Abstract available


  122. KOCHI M, Kohagura K, Shiohira Y, Iseki K, et al
    Inflammation as a Risk of Developing Chronic Kidney Disease in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0160225.
    PubMed     Text format     Abstract available


  123. IKDAHL E, Rollefstad S, Hisdal J, Olsen IC, et al
    Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study.
    PLoS One. 2016;11:e0153440.
    PubMed     Text format     Abstract available


  124. PRIORESCHI A, Makda MA, Tikly M, McVeigh JA, et al
    In Patients with Established RA, Positive Effects of a Randomised Three Month WBV Therapy Intervention on Functional Ability, Bone Mineral Density and Fatigue Are Sustained for up to Six Months.
    PLoS One. 2016;11:e0153470.
    PubMed     Text format     Abstract available


  125. SONOMOTO K, Yamaoka K, Kaneko H, Yamagata K, et al
    Spontaneous Differentiation of Human Mesenchymal Stem Cells on Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold.
    PLoS One. 2016;11:e0153231.
    PubMed     Text format     Abstract available


  126. ENG GP, Bouchelouche P, Bartels EM, Bliddal H, et al
    Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study.
    PLoS One. 2016;11:e0162316.
    PubMed     Text format     Abstract available


  127. GONZALEZ-ALVARO I, Castrejon I, Ortiz AM, Toledano E, et al
    Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0161727.
    PubMed     Text format     Abstract available


  128. CUPPEN BV, Fu J, van Wietmarschen HA, Harms AC, et al
    Exploring the Inflammatory Metabolomic Profile to Predict Response to TNF-alpha Inhibitors in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0163087.
    PubMed     Text format     Abstract available


  129. DEY P, Panga V, Raghunathan S
    A Cytokine Signalling Network for the Regulation of Inducible Nitric Oxide Synthase Expression in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0161306.
    PubMed     Text format     Abstract available


  130. MORITA T, Shima Y, Wing JB, Sakaguchi S, et al
    The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis.
    PLoS One. 2016;11:e0162306.
    PubMed     Text format     Abstract available


  131. CHEN R, Schwander M, Barbe MF, Chan MM, et al
    Ossicular Bone Damage and Hearing Loss in Rheumatoid Arthritis: A Correlated Functional and High Resolution Morphometric Study in Collagen-Induced Arthritic Mice.
    PLoS One. 2016;11:e0164078.
    PubMed     Text format     Abstract available


  132. ISHIKAWA Y, Fujii T, Ishikawa SK, Yukawa N, et al
    Immunogenicity and Lupus-Like Autoantibody Production Can Be Linked to Each Other along With Type I Interferon Production in Patients with Rheumatoid Arthritis Treated With Infliximab: A Retrospective Study of a Single Center Cohort.
    PLoS One. 2016;11:e0162896.
    PubMed     Text format     Abstract available


  133. JEONG H, Chang YS, Baek SY, Kim SW, et al
    Evaluation of Audiometric Test Results to Determine Hearing Impairment in Patients with Rheumatoid Arthritis: Analysis of Data from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2016;11:e0164591.
    PubMed     Text format     Abstract available


  134. KIM JY, Lee EY, Park JK, Song YW, et al
    Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process.
    PLoS One. 2016;11:e0164564.
    PubMed     Text format     Abstract available


  135. MORINOBU A, Tanaka S, Nishimura K, Takahashi S, et al
    Expression and Functions of Immediate Early Response Gene X-1 (IEX-1) in Rheumatoid Arthritis Synovial Fibroblasts.
    PLoS One. 2016;11:e0164350.
    PubMed     Text format     Abstract available


  136. SUROWIEC I, Arlestig L, Rantapaa-Dahlqvist S, Trygg J, et al
    Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis.
    PLoS One. 2016;11:e0164196.
    PubMed     Text format     Abstract available


  137. LIM CH, Lin CH, Chen DY, Chen YM, et al
    One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study.
    PLoS One. 2016;11:e0166339.
    PubMed     Text format     Abstract available


  138. HURNAKOVA J, Hulejova H, Zavada J, Komarc M, et al
    Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.
    PLoS One. 2016;11:e0165498.
    PubMed     Text format     Abstract available


  139. SU FH, Wu CS, Sung FC, Chang SN, et al
    Correction: Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan.
    PLoS One. 2016;11:e0166508.
    PubMed     Text format     Abstract available


  140. ZHOU Q, Long L, Zhou T, Tian J, et al
    Demethylation of MicroRNA-124a Genes Attenuated Proliferation of Rheumatoid Arthritis Derived Fibroblast-Like Synoviocytes and Synthesis of Tumor Necrosis Factor-alpha.
    PLoS One. 2016;11:e0164207.
    PubMed     Text format     Abstract available


  141. KOBAYASHI Y, Ikeda K, Nakamura T, Yamagata M, et al
    Severity and Diurnal Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid Arthritis.
    PLoS One. 2016;11:e0166616.
    PubMed     Text format     Abstract available


  142. BLACK RJ, Hill CL, Lester S, Dixon WG, et al
    The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0166468.
    PubMed     Text format     Abstract available


  143. CHEN DY, Li JP, Chen YM, Liao TL, et al
    Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy.
    PLoS One. 2016;11:e0166301.
    PubMed     Text format     Abstract available


  144. ZHU H, Xia W, Mo XB, Lin X, et al
    Gene-Based Genome-Wide Association Analysis in European and Asian Populations Identified Novel Genes for Rheumatoid Arthritis.
    PLoS One. 2016;11:e0167212.
    PubMed     Text format     Abstract available


  145. PLESTILOVA L, Neidhart M, Russo G, Frank-Bertoncelj M, et al
    Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0166920.
    PubMed     Text format     Abstract available


  146. DE MITS S, Lenaerts J, Vander Cruyssen B, Mielants H, et al
    A Nationwide Survey on Patient's versus Physician s Evaluation of Biological Therapy in Rheumatoid Arthritis in Relation to Disease Activity and Route of Administration: The Be-Raise Study.
    PLoS One. 2016;11:e0166607.
    PubMed     Text format     Abstract available


  147. FISHER A, Bassett K, Goel G, Stanely D, et al
    Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis.
    PLoS One. 2016;11:e0168005.
    PubMed     Text format     Abstract available


  148. LEE DK, Kim HJ, Lee DH
    Incidence of Deep Vein Thrombosis and Venous Thromboembolism following TKA in Rheumatoid Arthritis versus Osteoarthritis: A Meta-Analysis.
    PLoS One. 2016;11:e0166844.
    PubMed     Text format     Abstract available


  149. GOMEZ-VAQUERO C, Martin I, Loza E, Carmona L, et al
    Effect of Osteoprotegerin and Dickkopf-Related Protein 1 on Radiological Progression in Tightly Controlled Rheumatoid Arthritis.
    PLoS One. 2016;11:e0166691.
    PubMed     Text format     Abstract available


  150. KUULIALA K, Kuuliala A, Koivuniemi R, Kautiainen H, et al
    STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis.
    PLoS One. 2016;11:e0167975.
    PubMed     Text format     Abstract available


  151. TRIER NH, Holm BE, Slot O, Locht H, et al
    Physical Characteristics of a Citrullinated Pro-Filaggrin Epitope Recognized by Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Sera.
    PLoS One. 2016;11:e0168542.
    PubMed     Text format     Abstract available


  152. KAO LT, Kang JH, Lin HC, Huang CC, et al
    Rheumatoid Arthritis Was Negatively Associated with Alzheimer's Disease: A Population-Based Case-Control Study.
    PLoS One. 2016;11:e0168106.
    PubMed     Text format     Abstract available


  153. MORI S, Hidaka M, Kawakita T, Hidaka T, et al
    Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    PLoS One. 2016;11:e0154744.
    PubMed     Text format     Abstract available


  154. MANOUSEK J, Stejskal V, Kubena P, Jarkovsky J, et al
    Delayed-Type Hypersensitivity to Metals of Environmental Burden in Patients with Takotsubo Syndrome - Is There a Clinical Relevance?
    PLoS One. 2016;11:e0164786.
    PubMed     Text format     Abstract available


  155. CHEN J, Zhao X, Liu H, Zhou S, et al
    A Point-Scoring System for the Clinical Diagnosis of Sjogren's Syndrome Based on Quantified SPECT Imaging of Salivary Gland.
    PLoS One. 2016;11:e0155666.
    PubMed     Text format     Abstract available


  156. YEH CC, Wang WC, Wu CS, Sung FC, et al
    Association of Sjogrens Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    PLoS One. 2016;11:e0161958.
    PubMed     Text format     Abstract available


    January 2015
  157. LOPEZ-MEJIAS R, Genre F, Remuzgo-Martinez S, Robustillo-Villarino M, et al
    Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.
    PLoS One. 2015;10:e0143153.
    PubMed     Text format     Abstract available


  158. PHILLIPS C, Zeringue AL, McDonald JR, Eisen SA, et al
    Tumor Necrosis Factor Inhibition and Head and Neck Cancer Recurrence and Death in Rheumatoid Arthritis.
    PLoS One. 2015;10:e0143286.
    PubMed     Text format     Abstract available


  159. NAZARI M, Mahmoudi M, Rahmani F, Akhlaghi M, et al
    Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis.
    PLoS One. 2015;10:e0143757.
    PubMed     Text format     Abstract available


  160. PAPAGEORGIOU A, Ziogas DC, Mavragani CP, Zintzaras E, et al
    Predicting the Outcome of Sjogren's Syndrome-Associated Non-Hodgkin's Lymphoma Patients.
    PLoS One. 2015;10:e0116189.
    PubMed     Text format     Abstract available


  161. IZUMI K, Kaneko Y, Hashizume M, Yoshimoto K, et al
    Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naive Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study).
    PLoS One. 2015;10:e0145468.
    PubMed     Text format     Abstract available


  162. MITTAL A, Pachter L, Nelson JL, Kjaergaard H, et al
    Pregnancy-Induced Changes in Systemic Gene Expression among Healthy Women and Women with Rheumatoid Arthritis.
    PLoS One. 2015;10:e0145204.
    PubMed     Text format     Abstract available


  163. AHN JK, Kim S, Hwang J, Kim J, et al
    Metabolomic Elucidation of the Effects of Curcumin on Fibroblast-Like Synoviocytes in Rheumatoid Arthritis.
    PLoS One. 2015;10:e0145539.
    PubMed     Text format     Abstract available


  164. OLKKONEN J, Kouri VP, Hynninen J, Konttinen YT, et al
    Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1beta and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis.
    PLoS One. 2015;10:e0145279.
    PubMed     Text format     Abstract available


  165. NIKOLAUS S, Bode C, Taal E, Vonkeman HE, et al
    Construct Validation of a Multidimensional Computerized Adaptive Test for Fatigue in Rheumatoid Arthritis.
    PLoS One. 2015;10:e0145008.
    PubMed     Text format     Abstract available


  166. HASHIMOTO M, Yamazaki T, Hamaguchi M, Morimoto T, et al
    Periodontitis and Porphyromonas gingivalis in preclinical stage of arthritis patients.
    PLoS One. 2015;10:e0122121.
    PubMed     Text format     Abstract available


  167. DENG C, Hu C, Chen S, Li J, et al
    Meta-analysis of anti-muscarinic receptor type 3 antibodies for the diagnosis of Sjogren syndrome.
    PLoS One. 2015;10:e0116744.
    PubMed     Text format     Abstract available


  168. LEE CT, Kokolus KM, Leigh ND, Capitano M, et al
    Defining immunological impact and therapeutic benefit of mild heating in a murine model of arthritis.
    PLoS One. 2015;10:e0120327.
    PubMed     Text format     Abstract available


  169. LEE H, Park HY, Jeon K, Jeong BH, et al
    QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment.
    PLoS One. 2015;10:e0119260.
    PubMed     Text format     Abstract available


  170. KARLSEN M, Hansen T, Nordal HH, Brun JG, et al
    Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjogren's syndrome.
    PLoS One. 2015;10:e0120383.
    PubMed     Text format     Abstract available


  171. FILER A, Antczak P, Parsonage GN, Legault HM, et al
    Stromal transcriptional profiles reveal hierarchies of anatomical site, serum response and disease and identify disease specific pathways.
    PLoS One. 2015;10:e0120917.
    PubMed     Text format     Abstract available


  172. LISOWSKA B, Lisowski A, Siewruk K
    Substance P and Chronic Pain in Patients with Chronic Inflammation of Connective Tissue.
    PLoS One. 2015;10:e0139206.
    PubMed     Text format     Abstract available


  173. LAVIELLE P, Talavera JO, Reynoso N, Gonzalez M, et al
    Prevalence of Cognitive Impairment in Recently Diagnosed Type 2 Diabetes Patients: Are Chronic Inflammatory Diseases Responsible for Cognitive Decline?
    PLoS One. 2015;10:e0141325.
    PubMed     Text format     Abstract available


  174. JUNG YJ, Woo HI, Jeon K, Koh WJ, et al
    The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-alpha Antagonist Therapy.
    PLoS One. 2015;10:e0141033.
    PubMed     Text format     Abstract available


    January 2014
  175. KERN J, Drutel R, Leanhart S, Bogacz M, et al
    Reduction of T Cell Receptor Diversity in NOD Mice Prevents Development of Type 1 Diabetes but Not Sjogren's Syndrome.
    PLoS One. 2014;9:e112467.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: